Weekly NIH Funding Opportunities and Notices

Limited Competition: Small Grant Program for NIDDK K01/K08/K23/K25 Recipients (R03 Clinical Trial Optional)
(PAR-19-365)
National Institute of Diabetes and Digestive and Kidney Diseases
Application Receipt Date(s): Standard dates apply
Institutional Research and Academic Career Development Awards (IRACDA) (K12 - Independent Clinical Trial Not Allowed)
(PAR-19-366)
National Institute of General Medical Sciences
Application Receipt Date(s): November 13, 2019; October 1, 2020; October 1, 2021 All applications are due by 5:00 PM local time of applicant organization. All types of applications allowed for this funding opportunity announcement are due on the listed date(s). Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
Maximizing Investigators' Research Award (R35 - Clinical Trial Optional)
(PAR-19-367)
National Institute of General Medical Sciences
Application Receipt Date(s): January 17, 2020; May 18, 2020; January 19, 2021; May 17, 2021; January 18, 2022, May 17, 2022
Accelerating the Pace of Drug Abuse Research Using Existing Data (R01 Clinical Trial Optional) (PAR-19-368)
National Institute on Drug Abuse National Institute on Alcohol Abuse and Alcoholism
Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. The first standard application due date for this FOA is October 5, 2019. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
Development of Animal Models and Related Biological Materials for Research (R21 Clinical Trial Not Allowed)
(PAR-19-369)
Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure Programs
Application Receipt Date(s): Standard dates apply , by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. The first standard application due date for this FOA is October 1?6, 2019.
NIDCR Small Grant Program for New Investigators (R03 Clinical Trial Not Allowed)
(PAR-19-370)
National Institute of Dental and Craniofacial Research
Application Receipt Date(s): Standard dates apply by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. The first standard application due date for this FOA is October 1?6, 2019.
NIAID Career Transition Award (K22 Independent Clinical Trial Not Allowed)
(PAR-19-371)
National Institute of Allergy and Infectious Diseases
Application Receipt Date(s): Standard dates apply. The first standard due date for this FOA is, October 12, 2019. All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s). Applications are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
Social Epigenomics Research Focused on Minority Health and Health Disparities (R01-Clinical Trial Not Allowed)
(PAR-19-372)
National Institute on Minority Health and Health Disparities
National Institute on Aging
Application Receipt Date(s): November 6, 2019, November 6, 2020, November 8, 2021
Complex Integrated Multi-Component Projects in Aging Research (U19 Clinical Trial Optional) (PAR-19-374)
National Institute on Aging
Application Receipt Date(s): Standard dates apply. The first standard due date for this FOA is January 25, 2020. All applicants are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s). Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
Small Research Grants for Analyses of Gabriella Miller Kids First Pediatric Research Data (R03 Clinical Trial Not Allowed)
(PAR-19-375)
Eunice Kennedy Shriver
National Institute of Child Health and Human Development
National Cancer Institute
National Heart, Lung, and Blood Institute
National Institute of Dental and Craniofacial Research
Application Receipt Date(s): Standard dates apply , The first standard application due date for this FOA is February 16, 2020..
Mobile Health: Technology and Outcomes in Low and Middle Income Countries (R21/R33 - Clinical Trial Optional)
(PAR-19-376)
John E. Fogarty International Center
National Cancer Institute
National Institute of Biomedical Imaging and Bioengineering
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institute on Deafness and Other Communication Disorders
National Institute of Mental Health
National Institute of Neurological Disorders and Stroke
Office of Behavioral and Social Science Research
Office of Research on Women's Health
Application Receipt Date(s): November 19, 2019; September 24, 2020
Omics-guided Biobehavioral Interventions for Improved Health Outcomes: A Step Forward in Translation (R01 Clinical Trial Optional)
(PAR-19-377)
National Institute of Nursing Research
Application Receipt Date(s): Standard dates apply The first standard due date for this FOA is February 5, 2020 All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s) Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
MD-PhD Training Program in Alzheimer's Disease and Related Dementias and the Behavioral and Social Sciences (T32 Clinical Trial Not Allowed)
(RFA-AG-20-032)
National Institute on Aging Application
Receipt Date(s): October 28, 2019 No late applications will be accepted for this funding opportunity announcement. All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s). Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
Tailoring Interventions to Improve Preventive Health Service Use (R61/R33 Clinical Trial Required) (RFA-AG-20-045)
National Institute on Aging
Office of Disease Prevention
Application Receipt Date(s): October 28, 2019
Advancing Sustained/Extended Release for HIV Prevention (A-SER) (R01 Clinical Trial Not Allowed)
(RFA-AI-19-063)
National Institute of Allergy and Infectious Diseases
National Institute of Mental Health
Application Receipt Date(s): Only accepting applications for the AIDS Application Due Date listed below.
Informatics Technology for Cancer Research Education Center (UE5 Clinical Trials Not Allowed) (RFA-CA-19-042)
National Cancer Institute
Application Receipt Date(s): December 19, 2019; July31, 2020 No late applications will be accepted for this Funding opportunity Announcement. All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s). Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
Limited Competition: AIDS Malignancy Consortium (AMC) (UM1 Clinical Trials Required)
(RFA-CA-19-056)
National Cancer Institute
Application Receipt Date(s): Only accepting applications for the AIDS Application Due Date(s) listed below.
Improving the Reach and Quality of Cancer Care in Rural Populations (R01 Clinical Trial Required) (RFA-CA-19-064)
National Cancer Institute
Application Receipt Date(s): January 15, 2020
The Rat Opioid Genome Project: Clinical Trials not Allowed (U01- Clinical Trial Not Allowed)
(RFA-DA-20-010)
National Institute on Drug Abuse
Application Receipt Date(s): November 19, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date. No late applications will be accepted for this Funding Opportunity Announcement. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
NIDDK Cooperative Centers of Excellence in Hematology (U54 Clinical Trial Not Allowed)
(RFA-DK-19-005)
National Institute of Diabetes and Digestive and Kidney Diseases
Application Receipt Date(s): November 21, 2019 and June 30, 2020 All applicants are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s). Applicants are encouraged to allow adequate time to make any apply corrections to errors found in the application during the submission process by the due date.
Data Sharing for Demographic Research Infrastructure Program (R24 Clinical Trial Not Allowed) (RFA-HD-20-001)
Eunice Kennedy Shriver National Institute of Child Health and Human Development
Application Receipt Date(s): November 29, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date.
Fertility and Fertility Preservation for Patients with Diseases that Previously Precluded Reproduction (R21 Clinical Trial Optional)
(RFA-HD-20-021)
Eunice Kennedy Shriver National Institute of Child Health and Human Development
Application Receipt Date(s): November 26, 2019
Stimulating Access to Research in Residency Transition Scholar (StARRTS) (K38) (Clinical Trial Not Allowed)
(RFA-HL-20-006)
National Heart, Lung, and Blood Institute
National Cancer Institute
National Institute on Aging
National Institute of Allergy and Infectious Diseases
Application Receipt Date(s): November 18, 2019; October 15, 2020; October 15, 2021, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s). Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
Enabling Technologies and Transformative Platforms for HLBS Research (R33 - Clinical Trials Not Allowed)
(RFA-HL-20-022)
National Heart, Lung, and Blood Institute
Application Receipt Date(s): November 8, 2019, March 9, 2020, July 9, 2020, March 9, 2021, July 9, 2021
Catalyze: Product Definition for Small Molecules and Biologics - Target Identification and Validation, and Preliminary Product/Lead Series Identification (R61/R33 Clinical Trials Not Allowed)
(RFA-HL-20-023)
National Heart, Lung, and Blood Institute
Application Receipt Date(s): November 8, 2019, March 9, 2020, July 9, 2020, March 9, 2021, July 9, 2021 by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
Catalyze: Product Definition Device Prototype Design and Testing, Diagnostic Disease Target Identification and Assay Development, and Research Tool Development (R61/R33 - Clinical Trial Not Allowed)
(RFA-HL-20-024)
National Heart, Lung, and Blood Institute
Application Receipt Date(s): November 8, 2019, March 9, 2020, March 9, 2021, July 9, 2021 by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
Catalyze: Product Definition for Small Molecules and Biologics - Preliminary Product/Lead Series Identification (R33 - Clinical Trial Not Allowed)
(RFA-HL-20-027)
National Heart, Lung, and Blood Institute
Application Receipt Date(s): November 8, 2019, March 9, 2020, July 9, 2020, March 9, 2021, July 9, 2021, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
Catalyze: Product Definition Device Prototype Testing and Design Modification, Diagnostic Disease Target Assay Development and Design Characterization, and Research Tool Testing and Validation (R33 - Clinical Trials Not Allowed)
(RFA-HL-20-028)
National Heart, Lung, and Blood Institute
Application Receipt Date(s): November 8, 2019, March 9, 2020, March 9, 2021, July 9, 2021 by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on thesedates.
Bench to Bassinet Program Administrative Coordinating Center (U01 - Clinical Trial Not Allowed) (RFA-HL-21-002)
National Heart, Lung, and Blood Institute
Application Receipt Date(s): March 6, 2020
Resource-Related Research Projects for Development of Animal Models and Related Materials (R24 Clinical Trials Not-Allowed)
(RFA-OD-19-027)
Division of Program Coordination, Planning and Strategic Initiatives,
Office of Research Infrastructure Programs
Application Receipt Date(s): October 28, 2019, January 27, 2020, May 27, 2020, September 28, 2020, January 26, 2021, May 26, 2021, September 28, 2021 and January 26, 2022, May 26, 2022 apply, by 5:00 PM local time of applicant organization.nsert Guide text here.